Search research articles
Contact Us
Filters
Showing results (601-610 of 836) with videos related to
Page
of 84
Sort By:
Intestinal Research
|
December 3, 2025
Effectiveness, safety, and pharmacokinetics of the infliximab biosimilar CT-P13 after non-medical switch from the infliximab originator in patients with inflammatory bowel disease
Ryohei Nomaru, Teruyuki Takeda, Atsushi Takahashi, et al.
Intestinal Research
|
November 14, 2025
The impact of inflammatory bowel disease on women's health: a cross sectional study in India
Arshia Bhardwaj, Arshdeep Singh, Riya Sharma, et al.
Intestinal Research
|
December 12, 2025
Fecal surrogate markers strongly correlate with endoscopic findings in pediatric onset inflammatory bowel disease: a retrospective study in Japan
Ryoko Yoshimura, Takahiro Kudo, Masanori Toda, et al.
Intestinal Research
|
November 6, 2025
Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international survey
Charlotte Wong, Johan Burisch, Ryan C Ungaro, et al.
Intestinal Research
|
June 23, 2025
A real-world comparison of subcutaneous to intravenous administration of infliximab in patients with inflammatory bowel disease
Kwang Woo Kim, Hyoun Woo Kang, Seong-Joon Koh, et al.
Intestinal Research
|
May 14, 2025
Lifestyle restrictions are associated with impaired quality of life but not reduction in relapse in ulcerative colitis
Hajime Yamazaki, Masakazu Nagahori, Tadakazu Hisamatsu, et al.
Intestinal Research
|
April 25, 2025
Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database
Katsuyoshi Matsuoka, Ataru Igarashi, Noriko Sato, et al.
Intestinal Research
|
September 29, 2025
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
Antonio Tursi, Giammarco Mocci, Francesco Costa, et al.
Intestinal Research
|
February 9, 2026
First-line biologic therapy selection highly impacts ulcerative colitis outcomes: results from the APPETISER study
Diari M'Baye, Marianne Hupé, Marie Dodel, et al.
Intestinal Research
|
February 3, 2026
Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile
Ki Sung Kang, Gee Hyeun Choi, Yu Jin Kim, et al.
Page
of 84
Search research articles
Search
Showing results (601-610 of 836) with videos related to
Sort By:
Page
of 84
Intestinal Research
|
December 3, 2025
Effectiveness, safety, and pharmacokinetics of the infliximab biosimilar CT-P13 after non-medical switch from the infliximab originator in patients with inflammatory bowel disease
Ryohei Nomaru, Teruyuki Takeda, Atsushi Takahashi, et al.
Intestinal Research
|
November 14, 2025
The impact of inflammatory bowel disease on women's health: a cross sectional study in India
Arshia Bhardwaj, Arshdeep Singh, Riya Sharma, et al.
Intestinal Research
|
December 12, 2025
Fecal surrogate markers strongly correlate with endoscopic findings in pediatric onset inflammatory bowel disease: a retrospective study in Japan
Ryoko Yoshimura, Takahiro Kudo, Masanori Toda, et al.
Intestinal Research
|
November 6, 2025
Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international survey
Charlotte Wong, Johan Burisch, Ryan C Ungaro, et al.
Intestinal Research
|
June 23, 2025
A real-world comparison of subcutaneous to intravenous administration of infliximab in patients with inflammatory bowel disease
Kwang Woo Kim, Hyoun Woo Kang, Seong-Joon Koh, et al.
Intestinal Research
|
May 14, 2025
Lifestyle restrictions are associated with impaired quality of life but not reduction in relapse in ulcerative colitis
Hajime Yamazaki, Masakazu Nagahori, Tadakazu Hisamatsu, et al.
Intestinal Research
|
April 25, 2025
Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database
Katsuyoshi Matsuoka, Ataru Igarashi, Noriko Sato, et al.
Intestinal Research
|
September 29, 2025
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study
Antonio Tursi, Giammarco Mocci, Francesco Costa, et al.
Intestinal Research
|
February 9, 2026
First-line biologic therapy selection highly impacts ulcerative colitis outcomes: results from the APPETISER study
Diari M'Baye, Marianne Hupé, Marie Dodel, et al.
Intestinal Research
|
February 3, 2026
Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against Clostridioides difficile
Ki Sung Kang, Gee Hyeun Choi, Yu Jin Kim, et al.
Page
of 84